A South Korea based bioengineering company approached Freyr to file original ANDA and DMF applications to the USFDA. The challenge was to review all the documents as per the standards of the FDA and revising all the incompatible documents in the eCTD format.

Read the case study to decode how Freyr assisted the client with end-to-end publishing activities and provided valid submissions and cost benefits.